Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
---|---|---|---|---|
MCF7 | GSK2334470 | 0.003162278 | 0.8143 | 0.08099 |
MCF7 | GSK2334470 | 0.003162278 | 1.0712 | -0.00251 |
MCF7 | GSK2334470 | 0.01 | 0.7496 | 0.00378 |
MCF7 | GSK2334470 | 0.01 | 0.6707 | 0.00994 |
MCF7 | GSK2334470 | 0.01 | 0.9044 | 0.00127 |
MCF7 | GSK2334470 | 0.031622777 | 0.7335 | 0.00772 |
MCF7 | GSK2334470 | 0.031622777 | 0.7790 | 0.00586 |
MCF7 | GSK2334470 | 0.031622777 | 0.9379 | 0.00580 |
MCF7 | GSK2334470 | 0.1 | 0.9090 | 0.00159 |
MCF7 | GSK2334470 | 0.1 | 0.9507 | -0.00011 |
MCF7 | GSK2334470 | 0.1 | 0.9583 | 0.00216 |
MCF7 | GSK2334470 | 0.316227766 | 0.6277 | 0.00445 |
MCF7 | GSK2334470 | 0.316227766 | 0.8230 | 0.00707 |
MCF7 | GSK2334470 | 0.316227766 | 0.7415 | 0.00280 |
MCF7 | GSK2334470 | 1.0 | 0.4322 | 0.01377 |
MCF7 | GSK2334470 | 1.0 | 0.5996 | 0.08931 |
MCF7 | GSK2334470 | 1.0 | 0.6450 | 0.00987 |
MCF7 | GSK2334470 | 3.16227766 | 0.5054 | 0.00813 |
MCF7 | GSK2334470 | 3.16227766 | 0.6834 | 0.00962 |
MCF7 | GSK2334470 | 3.16227766 | 0.6222 | 0.01810 |
MCF7 | GSK2334470 | 10.0 | 0.2748 | 0.03623 |
MCF7 | GSK2334470 | 10.0 | 0.2955 | 0.05845 |
MCF7 | GSK2334470 | 10.0 | 0.3573 | 0.04581 |
MCF7 | Ribociclib | 0.001 | 0.8168 | -0.00054 |
MCF7 | Ribociclib | 0.001 | 0.9566 | -0.00276 |